TickerFacts.

Neonc Technologies Holdings, Inc. (NTHI): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$17.51M
As of 2025-12-31
-$18.53M
As of 2026-06-30
2024-12-31: -$5.50M2025-12-31: -$17.51M-$17.51M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$17.51Mn/m2026-03-31, Balance as of period end
2024-12-31-$5.50Mn/a2026-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31-$17.51Mn/m
Altimmune, Inc. (ALT)2025-12-31$224.89M+82.1%
Lyell Immunopharma, Inc. (LYEL)2025-12-31$248.20M-35.2%
Impact Biomedical Inc. (IBO)2025-12-31$12.61M+196.1%
HCW Biologics Inc. (HCWB)2025-12-31$2.76Mn/m
Talphera, Inc. (TLPH)2025-12-31$17.04M+112.9%
Avalo Therapeutics, Inc. (AVTX)2025-12-31$83.05M-37.6%
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$41.98M-54.5%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$24.10M-64.8%

Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗